Dapagliflozen May Decrease Fatal Risks of Heart Failure Associated With Higher Ejection Fraction
September 27th 2022For patients suffering from a higher left ventricular ejection fraction, a sodium-glucose cotransporter 2 inhibitor could decrease risk of hospitalization or death from heart failure.
Read More
Genomic Testing Framework for Chronic Kidney Disease Continues to Grow
September 27th 2022Investigators combine research discovery with technological development to determine whether the role of genomics in nephrology should remain with subspecialists or be integrated into general nephrology.
Read More